VRXANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as VRXAW
Veraxa Biotech AG - Post de-SPAC
Last filing: 20-F on Jun 16, 2026
$1.00−0.11 (-9.91%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Veraxa Biotech AG - Post de-SPAC's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
2 buys · 0 sales
Net bought $82.65K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Deck David Lukas | 25,502,836 | 18.00% | 13D (active) | Jun 10, 2026 |
| Xlife Sciences AG | 23,029,967 | 16.30% | 13D (active) | Jun 10, 2026 |
| European Molecular Biology Laboratory | 22,891,235 | 16.20% | 13D (active) | Jun 10, 2026 |
| Schoeni Gilbert Edgar | 22,539,749 | 15.90% | 13D (active) | Jun 10, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Christoph Rudiger Antz | Chief Executive Officer, Director | 5,000 | Aug 31, 2026 |
| Raju Sudir Willener | Chief Financial Officer | – | Sep 14, 2026 |
| Halem Carl von | Interim CFO | – | Aug 20, 2026 |
| Heinz Schwer | Chief Business Officer | – | Jun 9, 2026 |
| Torsten Georg Friedrich Buergermeister | Chief Financial Officer | – | Jun 9, 2026 |
| Oliver Rolf Baumann | Director | 5,773,618 | Aug 31, 2026 |
| Christoph Samuel Ziegler | Director | 7,932 | Jun 10, 2026 |
| Marc Gruninger | Director | – | Jun 10, 2026 |
| Warren Hosseinion | Director | 700,000 | Jun 9, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Oliver Rolf Baumann Director | Aug 27, 2026 | Buy | +50,000 | $1.50 | $75.00K | 5,773,618 |
| Christoph Rudiger Antz Chief Executive Officer, Director | Aug 27, 2026 | Buy | +5,000 | $1.53 | $7.65K | 5,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.